Armata Pharmaceuticals (ARMP) Cash & Equivalents Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 4.69% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -16.07% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -8.88% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 21.66% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 36.53% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -42.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.58% |
| Dec 31, 2025 | -16.37% |
| Sep 30, 2025 | -16.46% |
| Jun 30, 2025 | -51.19% |
| Mar 31, 2025 | -36.85% |
| Dec 31, 2024 | -3.34% |
| Sep 30, 2024 | 12.38% |
| Jun 30, 2024 | 14.62% |
| Mar 31, 2024 | 19.02% |
| Dec 31, 2023 | 11.91% |
| Sep 30, 2023 | 14.68% |
| Jun 30, 2023 | -14.29% |
| Mar 31, 2023 | 1.22% |
| Dec 31, 2022 | 35.03% |
| Sep 30, 2022 | 42.94% |
| Jun 30, 2022 | 41.00% |
| Mar 31, 2022 | 96.02% |
| Dec 31, 2021 | 2.11% |
| Sep 30, 2021 | -3.39% |
| Jun 30, 2021 | 4.37% |
| Mar 31, 2021 | 39.87% |
| Dec 31, 2020 | 23.42% |
| Sep 30, 2020 | 27.16% |
| Jun 30, 2020 | 30.21% |
| Mar 31, 2020 | 122.36% |
| Dec 31, 2019 | 5.54% |
| Sep 30, 2019 | 29.87% |
| Jun 30, 2019 | 22.68% |
| Mar 31, 2019 | -0.06% |
| Dec 31, 2018 | 1.03% |
| Sep 30, 2018 | 4.50% |
| Jun 30, 2018 | 2.43% |
| Mar 31, 2018 | -20.97% |
| Dec 31, 2017 | -7.96% |
| Sep 30, 2017 | -7.58% |
| Jun 30, 2017 | -10.62% |
| Mar 31, 2017 | -48.83% |
| Dec 31, 2016 | -36.83% |
| Sep 30, 2016 | -6.54% |
| Jun 30, 2016 | -1.10% |